BSSO/SSO Joint Virtual Tumor Board - Multidisciplinary Management of Pancreatic Ductal Adenocarcinoma

Activity Overview

The participants will be able to:

Address patients with resectable and borderline resectable PDAC in the light of new evidence
Effectively stage and define criteria for upfront surgery and for neoadjuvant chemo
Discuss the role of radiation therapy on neoadjuvant and adjuvant setting
Explore nuances of patient selection based on molecular profile. Does it matter for resectable and borderline resectable patients?

Moderators:
Héber Salvador, MD - AC Camargo Cancer Center, São Paulo, Brazil
Douglas S. Tyler, MD, FSSO - University of Texas Medical Branch, Texas, USA

Surgical Oncologists:
1) Marciano Anghinoni (BSSO) - Hospital São Vicente, Curitiba – PR, Brazil
2) Felipe Coimbra (BSSO) – AC Camargo Cancer Center, São Paulo – SP, Brazil
3) Peter Allen, MD, FSSO (SSO) – Duke University, USA
4) Cristina R. Ferrone, MD, MS (SSO) - Massachusetts General Hospital, USA

Medical Oncologist:
Paulo Hoff, MD, PhD (BSMO) – Rede D’Or, São Paulo – SP, Brazil

Radiation Oncologist:
Arthur Rosa, MD, PhD (BSRO) – Oncoclinicas, Salvador – BA, Brazil

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	No Credit Offered